Literature DB >> 19917171

Membranous nephropathy in rheumatoid arthritis: a case report.

N Maruotti1, A Corrado, A Gaudio, F P Cantatore.   

Abstract

Rheumatoid arthritis is a chronic disease characterized by inflammation, abnormal cellular and humoral immune responses, synovial hyperplasia and rarely by renal involvement, characterized principally by secondary amyloidosis and nephrotoxic effects related to drugs, while renal lesions directly due to the disease itself are infrequent. In this report we describe a patient with rheumatoid arthritis who developed membranous nephropathy associated with nephrotic syndrome while receiving adalimumab, an anti-tumour necrosis factor-alpha drug.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19917171

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  5 in total

1.  Membranous nephropathy caused by rheumatoid arthritis.

Authors:  Ayana Iida; Yukihiro Wada; Junichi Hayashi; Shohei Tachibana; Taro Inaba; Masayuki Iyoda; Kazuho Honda; Takanori Shibata
Journal:  CEN Case Rep       Date:  2019-04-29

2.  Rituximab-induced remission in a woman with coexisting rheumatoid arthritis and nephrotic syndrome.

Authors:  Mia Weiss; Omer Gendelman; Gilad Twig; Ana Tobar; Howard Amital
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

3.  Spectrum and prognosis of renal histopathological lesions in 56 Chinese patients with rheumatoid arthritis with renal involvement.

Authors:  Ti Zhang; Shaoshan Liang; Xiaopian Feng; Manna Li; Houan Zhou; Caihong Zeng; Jiong Zhang; Zhen Cheng
Journal:  Clin Exp Med       Date:  2020-02-11       Impact factor: 3.984

Review 4.  Renal involvement in autoimmune connective tissue diseases.

Authors:  Andreas Kronbichler; Gert Mayer
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

5.  Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy.

Authors:  Yen-Sung Huang; Shin-Huei Fu; Kuo-Cheng Lu; Jin-Shuen Chen; Hsin-Yi Hsieh; Huey-Kang Sytwu; Chia-Chao Wu
Journal:  Oncotarget       Date:  2017-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.